Daiwa Securities Group Inc. Eli Lilly & CO Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 135,365 shares of LLY stock, worth $106 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

135,365

Previous 113,390 19.38%

Holding current value

$106 Million

Previous $103 Million 16.82%

% of portfolio

0.55%

Previous 0.55%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $17 Million - $21.1 Million	21,975 Added 19.38%	135,365 $120 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $4.55 Million - $5.71 Million	6,276 Added 5.86%	113,390 $103 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $8.11 Million - $10.8 Million	13,694 Added 14.66%	107,114 $83.3 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $2.56 Million - $3.01 Million	4,865 Added 5.49%	93,420 $54.5 Million
Q3 2023 Nov 01, 2023	BUY	$434.7 - $599.3 $769,853 - $1.06 Million	1,771 Added 2.04%	88,555 $47.6 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $511,378 - $683,772	1,458 Added 1.71%	86,784 $40.7 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $4.11 Million - $4.83 Million	13,239 Added 18.37%	85,326 $29.3 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $884,584 - $1.03 Million	2,751 Added 3.97%	72,087 $26.4 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $75,898 - $86,494	256 Added 0.37%	69,336 $22.4 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $493,352 - $579,267	1,770 Added 2.63%	69,080 $22.4 Million
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $537,440 - $667,901	-2,290 Reduced 3.29%	67,310 $19.3 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $1.65 Million - $2.05 Million	7,335 Added 11.78%	69,600 $19.2 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $360,321 - $443,426	-1,626 Reduced 2.54%	62,265 $14.4 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $919,902 - $1.19 Million	-5,095 Reduced 7.39%	63,891 $14.7 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $3.87 Million - $5.01 Million	-23,567 Reduced 25.46%	68,986 $12.9 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $5.56 Million - $7.35 Million	42,582 Added 85.21%	92,553 $15.6 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $288,784 - $334,031	1,975 Added 4.11%	49,971 $7.4 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $1.12 Million - $1.39 Million	9,411 Added 24.39%	47,996 $6.66 Million
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $248,268 - $307,502	2,322 Added 6.4%	38,585 $5.07 Million
Q3 2019 Nov 04, 2019	BUY	$106.79 - $116.16 $111,381 - $121,154	1,043 Added 2.96%	36,263 $4.06 Million
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $700,303 - $817,431	-6,321 Reduced 15.22%	35,220 $3.9 Million
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $805,884 - $948,584	-7,240 Reduced 14.84%	41,541 $5.39 Million
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $141,482 - $158,503	1,336 Added 2.82%	48,781 $5.65 Million
Q3 2018 Nov 01, 2018	BUY	$85.86 - $107.31 $652,536 - $815,556	7,600 Added 19.07%	47,445 $5.09 Million
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $497,500 - $570,975	-6,572 Reduced 14.16%	39,845 $3.4 Million
Q1 2018 May 02, 2018	BUY	$74.21 - $87.6 $179,513 - $211,904	2,419 Added 5.5%	46,417 $3.59 Million
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $98,737 - $105,907	1,205 Added 2.82%	43,998 $3.72 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $3.3 Million - $3.66 Million	42,793	42,793 $3.66 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Eli Lilly & CO Transaction History